Mainz Biomed Bv Stock Probability of Future Stock Price Finishing Over 5.88

MYNZ Stock  USD 0.74  0.03  3.90%   
Mainz Biomed's future price is the expected price of Mainz Biomed instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Mainz Biomed BV performance during a given time horizon utilizing its historical volatility. Check out Mainz Biomed Backtesting, Mainz Biomed Valuation, Mainz Biomed Correlation, Mainz Biomed Hype Analysis, Mainz Biomed Volatility, Mainz Biomed History as well as Mainz Biomed Performance.
  
At this time, Mainz Biomed's Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.06 in 2024, whereas Price To Sales Ratio is likely to drop 19.99 in 2024. Please specify Mainz Biomed's target price for which you would like Mainz Biomed odds to be computed.

Mainz Biomed Target Price Odds to finish over 5.88

The tendency of Mainz Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 5.88  or more in 90 days
 0.74 90 days 5.88 
close to zero percent
Based on a normal probability distribution, the odds of Mainz Biomed to move over $ 5.88  or more in 90 days from now is close to zero percent (This Mainz Biomed BV probability density function shows the probability of Mainz Stock to fall within a particular range of prices over 90 days) . Probability of Mainz Biomed BV price to stay between its current price of $ 0.74  and $ 5.88  at the end of the 90-day period is close to 99 .
Given the investment horizon of 90 days Mainz Biomed BV has a beta of -0.16. This indicates as returns on the benchmark increase, returns on holding Mainz Biomed are expected to decrease at a much lower rate. During a bear market, however, Mainz Biomed BV is likely to outperform the market. Additionally Mainz Biomed BV has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
   Mainz Biomed Price Density   
       Price  

Predictive Modules for Mainz Biomed

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Mainz Biomed BV. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mainz Biomed's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.040.746.08
Details
Intrinsic
Valuation
LowRealHigh
0.152.968.30
Details
Naive
Forecast
LowNextHigh
0.010.746.08
Details
2 Analysts
Consensus
LowTargetHigh
8.809.6710.73
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Mainz Biomed. Your research has to be compared to or analyzed against Mainz Biomed's peers to derive any actionable benefits. When done correctly, Mainz Biomed's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Mainz Biomed BV.

Mainz Biomed Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Mainz Biomed is not an exception. The market had few large corrections towards the Mainz Biomed's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Mainz Biomed BV, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Mainz Biomed within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.27
β
Beta against NYSE Composite-0.16
σ
Overall volatility
0.09
Ir
Information ratio -0.07

Mainz Biomed Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Mainz Biomed for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Mainz Biomed BV can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Mainz Biomed BV generated a negative expected return over the last 90 days
Mainz Biomed BV has high historical volatility and very poor performance
Mainz Biomed BV has some characteristics of a very speculative penny stock
Mainz Biomed BV has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 895.48 K. Net Loss for the year was (26.3 M) with profit before overhead, payroll, taxes, and interest of 177.62 K.
Mainz Biomed BV currently holds about 26.01 M in cash with (21.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.8, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Mainz Biomed BV has a frail financial position based on the latest SEC disclosures
Roughly 22.0% of the company outstanding shares are owned by corporate insiders
Latest headline from finance.yahoo.com: mRNA Is Promising A Breakthrough In Fighting Cancer

Mainz Biomed Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Mainz Stock often depends not only on the future outlook of the current and potential Mainz Biomed's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mainz Biomed's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding16.2 M
Cash And Short Term Investments7.1 M

Mainz Biomed Technical Analysis

Mainz Biomed's future price can be derived by breaking down and analyzing its technical indicators over time. Mainz Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Mainz Biomed BV. In general, you should focus on analyzing Mainz Stock price patterns and their correlations with different microeconomic environments and drivers.

Mainz Biomed Predictive Forecast Models

Mainz Biomed's time-series forecasting models is one of many Mainz Biomed's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Mainz Biomed's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Mainz Biomed BV

Checking the ongoing alerts about Mainz Biomed for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Mainz Biomed BV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Mainz Biomed BV generated a negative expected return over the last 90 days
Mainz Biomed BV has high historical volatility and very poor performance
Mainz Biomed BV has some characteristics of a very speculative penny stock
Mainz Biomed BV has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 895.48 K. Net Loss for the year was (26.3 M) with profit before overhead, payroll, taxes, and interest of 177.62 K.
Mainz Biomed BV currently holds about 26.01 M in cash with (21.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.8, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Mainz Biomed BV has a frail financial position based on the latest SEC disclosures
Roughly 22.0% of the company outstanding shares are owned by corporate insiders
Latest headline from finance.yahoo.com: mRNA Is Promising A Breakthrough In Fighting Cancer
When determining whether Mainz Biomed BV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mainz Biomed's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mainz Biomed Bv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mainz Biomed Bv Stock:

Complementary Tools for Mainz Stock analysis

When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Is Mainz Biomed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mainz Biomed. If investors know Mainz will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mainz Biomed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.62)
Revenue Per Share
0.055
Quarterly Revenue Growth
0.111
Return On Assets
(0.93)
Return On Equity
(3.03)
The market value of Mainz Biomed BV is measured differently than its book value, which is the value of Mainz that is recorded on the company's balance sheet. Investors also form their own opinion of Mainz Biomed's value that differs from its market value or its book value, called intrinsic value, which is Mainz Biomed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mainz Biomed's market value can be influenced by many factors that don't directly affect Mainz Biomed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mainz Biomed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mainz Biomed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mainz Biomed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.